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 Introduction 
 Perfusion MR imaging following a bolus injection of 
contrast agents provides useful information about vascu-
larization. Angiogenesis is a complex process regulated 
by multiple stimulatory and inhibitory factors that are 
able to modulate the migration and/or proliferation of 
microvascular cells with the objective of formation of 
neovasculature from pre-existing vessels  [1] . Angiogen-
esis is linked to tumor type (for example, glioblastoma is 
the most angiogenic tumor  [2] ) and angiogenesis explora-
tion is a challenge because diagnostic and therapeutic de-
cisions depend on tumor type  [3–5] . With the develop-
ment of anti-angiogenic therapy, the angiogenic process 
needs to be controlled regularly. Nowadays, these con-
trols need contrast-injected perfusion imaging but con-
trast injection may be impossible for different reasons 
like renal failure, nephrogenic systemic fibrosis  [6] or 
previous reactions. Arterial spin labeling (ASL) could be 
an alternative to standard intravenous bolus T2 * perfu-
sion. The measurement of cerebral blood flow (CBF) can 
be assessed with ASL, which uses magnetically labeled 
arterial blood water as an endogenous tracer and is based 
on magnetic resonance imaging (MRI). As Golay and Pe-
tersen  [7] described, ASL is a very low signal-to-noise ra-
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 Abstract 
 Purpose: To prove the feasibility of arterial spin labeling (ASL) 
to explore brain tumors by comparing dynamic susceptibility 
contrast-enhanced MRI to ASL at 3T MR.  Materials and Meth-
ods: Twenty-seven patients were included presenting 9 glio-
mas, 10 metastases and 8 meningiomas. All were explored by 
a pseudo-continuous ASL and dynamic susceptibility con-
trast-enhanced T2 * perfusion sequence. Two neuroradiolo-
gists analyzed the cerebral blood flow (CBF) maps to assess 
feasibility, examination quality and quantitative comparison. 
The Spearman nonparametric correlation test and the Bland-
Altman graphic test were used to analyze our quantitative 
results.  Results: 92% of ASL CBF maps were informative. ASL 
detected all lesions as well as dynamic susceptibility contrast-
enhanced MRI. Both sequences provide relative quantitative 
CBF values closely correlated.  Conclusion: On a 3T MR unit, 
ASL is a good alternative to dynamic susceptibility contrast-
enhanced MRI when contrast medium is contraindicated or 
intravenous injection is not possible. Its results on relative 
CBF parameters are similar to contrast-injected perfusion. 
tio (SNR) technique. Moving from 1.5 to 3T allows an 
SNR increase but not as attempted. The T1 tissue magne-
tization increases; the alteration of spin-spin relaxation 
T2 and the T2 * reduction limit the general SNR achiev-
able. Another determinant factor is the main field homo-
geneity which is much lower at 3T than at 1.5T. In conse-
quence, acquisition needs the use of pulses with larger 
bandwidth; inhomogeneity also contributes to the wors-
ening of artefacts in EPI images. Authors  [8] had com-
pared ASL with high to ASL with low field and proved the 
high-field superiority; furthermore, high-field MR units 
allow shorter acquisition time and a clinical use of this 
technique. Our purpose was to prove the feasibility of 
ASL to explore brain tumors by comparing standard in-
travenous bolus T2 * perfusion with ASL perfusion.
 Materials and Methods 
 Patients 
 A prospective study was conducted from October 2007 to 
March 2008. The local committee approved this study, patients 
were informed orally and consent was obtained; signed consent 
was not needed. The study was a consecutive series and 27 patients 
with cerebral tumors were included (sex ratio M/F: 19/8; mean age 
58 years, min 19, max 82): 8 cases with glioma (2 grade 2, 4 glio-
blastoma, 1 oligodendroglioma and 1 oligoastrocytoma), 5 with 
meningioma and 5 with metastasis were confirmed histologically, 
but the other 9 were not (5 metastasis with other locations known, 
3 meningioma and 1 low-grade glioma).
 MR Imaging Data Acquisition 
 All patients were examined with a 3T clinical MR imaging 
unit (HDX; General Electric Medical System, Milwaukee, Wisc., 
USA); 8-channel bird cage coil. Patients protocols are as follows: 
 Morphological sequences: Axial Fast SE T2, Axial SE T1, Ax-
ial FLAIR and 3D T1 after contrast injection. 
 Perfusion sequences:
 • Before injection of contrast agent: ASL perfusion: repetition
time: 9.4 ms, echo time: 2 ms, flip angle: 155°, field of view: 24 
 ! 24 cm 2 , slice thickness: 4 mm, NEX: 2, number of inter-
leaved slices: 92, duration: 3 min 52 s.
 • During an automatic bolus injection of contrast agent (MAG-
NEVIST  , gadopentate dimeglumine; Bayer Sante, Puteaux,
France) (0.1 mmol/kg), dynamic susceptibility contrast-en-
hanced MRI (DSC), axial echo-planar gradient echo imaging
 [9] : echo time: 30 ms, repetition time: 1,500 ms, flip angle: 60°,
matrix: 128  !  128, field of view: 24  ! 24 cm 2 , slice thickness:
5 mm, intersection gap: 1 mm, NEX: 1, number of slices: 20
from 65 scans. To optimize the signal-to-noise ratio and base-
line, we used fat saturation on this sequence.
 ASL uses the magnetization of water protons in the arterial
blood stream as an endogenous, freely diffusible tracer for perfu-
sion measurements. Any perturbation to the magnetization of the 
arterial blood that feeds the tissue can serve as a magnetic tracer. 
The perturbation is typically introduced by an RF inversion pulse 
at an upstream location to the tissue of interest. After a time delay 
that allows the magnetically labeled arterial blood to reach the 
tissue capillary bed, the labeled water molecules exchange with 
the water molecules in the tissue, causing a change in the MR sig-
nal. The spatially resolved signal change is measured by subtract-
ing the two images acquired with labeling (label image) and with-
out labeling (control image). The signal intensity change between 
label image and control image is fitted to a model from which a 
quantitative perfusion map of CBF is obtained. Theoretically, ASL 
can provide absolute values because blood properties are not af-
fected by administration of contrast. ASL allows this determina-
tion and is not affected by blood-brain barrier rupture.
 The difference image can also be viewed directly as a qualita-
tive perfusion-weighted image.
 The sequence (see ‘Appendix’) provided by GE Healthcare per-
forms a pseudo continuous spin labeling for 1.5 s before a post-
spin-labeling delay of 1.5 s. Background suppression for removing 
static tissue signal is optimized with saturation pulses. The image 
acquisition is a stack of interleaved spirals fast spin echo. The du-
ration of each spiral is 4 ms readout. The host reconstruction is 
made using the interactive data language (IDL) code run on the 
scanner with the IDL virtual machine. The images are filtered with 
Fermi windowing to reduce ringing. Grad warp is not currently 
applied. After reconstruction, the images were converted into the 
DICOM format and inserted into the database. If at least two phas-
es are selected, such that a reference image is available, then the 
difference images are converted to quantitative blood flow maps.
 Data Analysis 
 Image processing was performed using Advantage Windows 
4.4 workstation (GE Medical Systems). DSC CBF maps were ana-
lyzed by functool software (GE Medical Systems), ASL CBF maps 
were generated automatically. Two neuroradiologists compare the 
perfusion sequences (consensus). We performed:
 • On ASL, an examination quality analysis using a 4-point scale 
and artefacts detection: examination quality: 0 = unreadable,
1 = poor, 2 = moderate, 3 = good.
 • A qualitative comparison of the 2 sequences (ASL and stan-
dard intravenous bolus T2 * perfusion) based on tumor detec-
tion: 0 = no detection, 1 = fair, 2 = good.
 • A quantitative comparison ( fig. 1 ): Based on FLAIR images to
delineate peritumoral hypersignal and T1-weighted post-gad-
olinium images to delineate the edges of the tumor, we drew 2 
regions of interest (ROI) in the tumor for each patient. We also 
drew a ROI on contralateral brain white matter to normalize
our measures. We especially looked at cerebral blood flow
(CBF) normalized with the contralateral normal ROI: rCBF.
 Statistical Analysis 
 Spearman’s nonparametric correlation test and the Bland-Alt-
man graphic test were used to analyze our perfusion results.
 Results  ( table 1 ) 
 ASL Perfusion Examination Quality 
 92.6% of ASL perfusion examinations were informa-
tive. Two examinations (patients 26 and 27) were unread-
able (score = 0) due to dental artefacts, 1 poor (score = 1), 
10 moderate (score = 2), and 14 good (score = 3).
a b c
 Fig. 1. ROI positioning (meningioma): 2 ROI were placed on the tumor (ROI 1 and 2), and 1 on the contralat-
eral normal white brain matter (ROI 3).  a T1 after contrast injection.  b ASL CBF map.  c Contrast-injected T2 * 
perfusion CBF map. 
Table 1. Q ualitative and quantitative results for the 27 patients
Patient 
No.
Sex Age Diagnostic Exam quality Qualitative comparison Quantitative comparison
read-
ability
arte-
facts
tumor detection ROI 1 R OI 2
ASL DSC ASL DSC ASL DSC
1 M 61 oligodendroglioma 2 no 1 1 0.54 0.39 0.39 0.74
2 F 54 meningioma 3 no 2 1 1.77 0.83 1.84 0.57
3 M 65 metastasis 2 no 1 1 1.15 1.42 0.85 0.77
4 F 74 meningioma 2 no 2 2 3.06 2.04 2.70 1.23
5 M 68 meningioma 3 no 2 2 1.41 4.14 4.83 3.31
6 M 80 meningioma 3 no 2 2 3.38 4.46 1.82 2.10
7 F 22 meningioma 3 no 2 2 2.51 2.83 2.86 2.50
8 M 65 metastasis 2 no 2 2 0.88 3.60 3.78 2.88
9 F 48 metastasis 3 no 2 1 0.32 0.38 0.40 0.40
10 F 69 metastasis 3 no 2 2 3.88 3.06 2.11 2.20
11 M 19 oligoastrocytoma 3 no 2 1 5.10 1.41 1.52 0.27
12 M 52 metastasis 3 no 2 2 4.22 3.35 0.80 0.27
13 F 56 metastasis 2 no 2 2 0.25 0.05 0.18 0.04
14 M 23 astrocytoma grade 2 3 no 2 2 5.07 1.05 0.36 0.28
15 M 60 astrocytoma grade 2 3 no 1 1 0.65 0.57 0.45 0.74
16 F 82 glioblastoma 3 no 2 2 3.16 1.69 2.67 1.80
17 M 62 glioblastoma 3 no 2 1 5.83 4.02 1.06 1.14
18 M 78 glioblastoma 2 no 2 1 2.15 1.43 1.30 0.61
19 M 40 low-grade glioma 3 no 0 0 0.64 0.96 0.65 0.63
20 M 55 glioblastoma 2 no 2 2 1.25 0.99 0.68 0.18
21 M 73 meningioma 2 no 2 2 7.59 3.90 4.34 1.57
22 M 69 meningioma 2 no 1 1 1.16 0.53 1.07 1.92
23 F 64 meningioma 1 no 2 2 5.60 3.76 5.23 4.08
24 M 63 metastasis 2 no 2 2
25 M 57 metastasis 3 no 0 0
26 M 59 metastasis 0 yes
27 M 49 metastasis 0 yes
 Comparison of Perfusion Sequences 
 Qualitative Comparison for Tumor Detection 
 ASL perfusion examinations were compared to DSC 
perfusion; the 2 examinations that were unreadable on 
ASL perfusion were not compared. In the 25 patients 
compared, all lesions but one (patient 25) were detected 
by the 2 sequences. Therefore, 5 lesions were detected 
with a good result (score = 2) by ASL perfusion and with 
a fair result (score = 1) by DSC perfusion. A 9-mm lesion 
(patient 25) was not detected by ASL or by DSC perfu-
sion.
 Quantitative Comparison 
 Twenty-three examinations were compared; 4 patients 
were not because of hemorrhagic lesions (patient 24), too 
small lesions (9 mm), not being visible on both the perfu-
sion sequences (patient 25), or poor examination quality 
(patients 26 and 27).
 Based on the results displayed in  table 1 , Spearman’s 
nonparametric correlation test was for ROI 1: r = 0.69,
p  ! 0.001 and for ROI 2: r = 0.784, p  ! 0.0001. These re-
sults showed a significant correlation between rCBF cal-
culated from the 2 perfusion sequences. The Bland-Alt-
man test confirmed the results for the ROI.
 Discussion 
 ASL provides perfusion that is comparable to contrast-
enhanced MR perfusion. There are several ASL tech-
niques, which are commonly classified as continuous 
(CASL  [10, 11] ) or pulsed ASL (PASL  [12, 13] ). CASL pro-
duces the largest ASL signal change, potentially the great-
est SNR, and can be advantageous. PASL is interesting 
because of its straightforward implementation and the 
high and stable tagging efficiency with respect to flow 
velocity. In contrast, CASL benefits from the longer and 
better temporally defined tagging bolus and is conse-
quently higher than in PASL. The popularity of CASL, 
however, has been mainly hindered by the requirement of 
a continuous-mode RF transmission, which is not always 
available on commercial imagers. Furthermore, the sen-
sitivity of adiabatic inversion to flow velocity leads to a 
tagging efficiency that is mostly around 90% and can be 
as low as 68% when the amplitude-modulating method is 
used  [14] . More recently, a train of discrete RF pulses was 
proposed to generate the tag and control states in ASL. 
This method, termed pseudocontinuous ASL (pCASL), 
has the potential of combining the advantages of PASL 
and CASL. It includes a longer tagging bolus and thus 
higher SNR, therefore providing a better balance between 
tagging efficiency and SNR  [14] .
 Here we propose to use the method described previ-
ously  [15, 16] for flow-driven adiabatic inversion that em-
ploys repeated RF pulses rather than continuous RF. This 
method potentially overcomes a number of the limitations 
of previous implementations of CASL. Furthermore, this 
sequence, provided by GE Healthcare, is a 3D sequence.
 Based on our results, ASL allows a three-dimensional 
whole exploration of brain tumors without an injection 
of contrast agents. Moreover, CBF maps are automatical-
ly created without human postprocessing and its short 
acquisition time (3 min 52 s) on a 3T MR unit allows a 
routinely clinical use. Previous studies on a 1.5T MR unit 
 [17–19] already show that ASL is a suitable method for the 
assessment of microvascular perfusion but the acquisi-
tion time was higher and clinical use more difficult. Fur-
thermore, compared to 1.5T previous studies, our study 
proves that a 3T MR unit can be used for ASL imaging 
without an increase of artefacts.
 Our results show that there is a close correlation be-
tween ASL and standard intravenous bolus T2 * perfusion 
in the determination of rCBF in cerebral tumors. Most of 
the maps obtained (92.6%) were interpretable, and the 2 
unreadable ones were linked to dental artefacts which 
also disturb the interpretation of DSC perfusion. The 
comparison we made shows good results in a qualitative 
and quantitative manner with a good correlation. The 
ASL provides similar information as DSC perfusion for 
rCBF measurement. Other ASL sequences had already 
been compared to DSC. Even if Ludemann et al.  [20] con-
clude that tumor perfusion values determined with a dif-
ferent technique are not comparable, studies on gliomas 
 [17, 21] or meningiomas  [18] found a good correlation be-
tween ASL and DSC for determination of CBF. We obtain 
the same conclusion with this pCASL sequence, and a re-
cent study led to the same conclusions  [22] . Like DSC per-
fusion, ASL can guide cerebral biopsy to the most angio-
genic part of the tumor  [23–25] . Some authors  [26] pro-
pose to associate ASL and diffusion-weighted imaging for 
permeability measurement.
 ASL presents limits. First of all, ASL only provides 
CBF quantification. But even if cerebral blood volume 
(CBV) obtained with DSC perfusion is the parameter 
used most often, several studies report the same diagnos-
tic value of CBF  [17, 27, 28] .
 CBF quantification may be affected by transit time 
which differs from gray to white matter  [29, 30] and may 
vary with patient age  [31] . Therefore, CBF may be under-
estimated with ASL at low flow rates.
 The entire posterior fossa exploration is not possible 
with this sequence because of the inversion labeling 
which makes the first centimeters unavailable. This lim-
it must be considered for posterior fossa tumors even if 
DSC perfusion often presents image distortion caused by 
susceptibility artefacts, chemical shift artefacts, or ghosts 
in the same region.
 Finally, continuous labeling requires near-continuous 
wave RF transmit capability that is often not available on 
imagers. Multislice implementations of CASL  [32, 33] 
suffer from signal attenuation, velocity sensitivity or im-
perfect static tissue subtraction or require special hard-
ware and labeling geometries.
 ALS presents majors advantages: first, for the patient, 
the fact that no contrast is used which is an advantage in 
patients who might develop nephrogenic systemic fibro-
sis, and, second, ASL is less susceptible to the effects of 
the blood barrier breakdown than contrast-enhanced 
MR perfusion.
 Conclusion 
 ASL perfusion is a good alternative to DSC perfusion 
when an injection of contrast agent is not possible. A 3T 
MR unit can be used for ASL imaging without an increase 
in artefacts and with an acceptable time for clinical use. 
This preliminary study on CBF parameters shows similar 
results to those obtained with conventional perfusion 
studies following an injection of contrast medium. Its role 
could also be considered for cerebral tumor follow-up.
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 Appendix 
 3D Spiral ASL Sequence and Quantification (12/10/07 
Version) 
 The prototype 3D ASL sequence is a combination of a back-
ground-suppressed CASL preparation, a 3D stack of spiral fse 
readout, and a host recon that reconstructs quantitative images. 
The three parts will be described in order.
 ASL Preparation 
 Continuous labeling is performed for 1.5 s prior to a postlabel-
ing delay that defaults to 1.5 s. Continuous labeling is achieved 
with the pulsed continuous approach introduced at the ISMRM 
in 2005  [16] and 2008  [15] . Our in vivo measurements indicate 
that the absolute efficiency of this pulsed continuous approach is 
81% for the parameters chosen here. Background suppression is 
achieved with a number of pulses (see figure below). Selective spa-
tial saturation and inversion are applied prior to labeling and then 
minimally selected inversions are applied after labeling to main-
tain background suppression. Inferior saturation pulses are ap-
plied at times corresponding to the background suppression nulls 
of blood to minimize artefacts from inflowing blood.
 Image Acquisition 
 The image acquisition is a stack of spirals fse. The number of 
slice echoes are acquired with centric ordering after each prepara-
tion. The spirals are interleaved and different interleaves are ac-
quired following different preparations.
 Quantification is performed as follows: 
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 where T1 of 1.6 s for blood at 3T or 1.4 s for blood at 1.5 T is as-
sumed. The partial saturation of the ‘PD’ reference image is cor-
rected for a T1 of 1.2 s typical of gray matter. While a more fully 
relaxed signal would be desirable, the saturation of the receiver 
and the bright signal on the slightly T2-weighted fse makes this 
undesirable. The partition coefficient,   , was set to the whole 
brain average, 0.9, and the efficiency,   , is set to 0.95  ! 0.75 to ac-
count for the combined efficiency of labeling and suppression. 
Our more recent numbers suggest this should be 0.8  !  0.75 so 
flow is underestimated by 15%. This quantification assumes the 
label remains in blood and thus T1 of the tissue, and the delay in 
the arrival time to the tissue, need not be quantified. 
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